• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hematogones in patients with acute myeloid leukaemia: Prognostic value and correlation with minimal residual disease.

作者信息

Tavarozzi Rita, Manzato Enrica, Morganti Riccardo, Sammuri Paola, Tarrini Giulia, Ricci Federica, Mattana Giordana, Galimberti Sara, Petrini Mario, Carulli Giovanni

机构信息

SC Hematology, AO N SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.

Sant'Anna School of Advanced Studies, Pisa, Italy.

出版信息

Leuk Res Rep. 2021 Jan 8;15:100234. doi: 10.1016/j.lrr.2021.100234. eCollection 2021.

DOI:10.1016/j.lrr.2021.100234
PMID:33489749
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7810761/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/373d/7810761/4cbe38f82540/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/373d/7810761/96c85aebbc37/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/373d/7810761/4cbe38f82540/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/373d/7810761/96c85aebbc37/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/373d/7810761/4cbe38f82540/gr2.jpg

相似文献

1
Hematogones in patients with acute myeloid leukaemia: Prognostic value and correlation with minimal residual disease.急性髓系白血病患者中的造血祖细胞：预后价值及与微小残留病的相关性。
Leuk Res Rep. 2021 Jan 8;15:100234. doi: 10.1016/j.lrr.2021.100234. eCollection 2021.
2
Analysis of hematogones in bone marrow from acute myeloid leukaemia cases posttherapy.治疗后急性髓系白血病患者骨髓中的造血细胞分析。
Eur J Clin Invest. 2013 Nov;43(11):1140-6. doi: 10.1111/eci.12151. Epub 2013 Sep 2.
3
Prognostic significance of CD56 and CD7 in acute myeloid leukaemia and their outcome.CD56和CD7在急性髓系白血病中的预后意义及其结果
Am J Blood Res. 2020 Aug 25;10(4):109-117. eCollection 2020.
4
Minimal residual disease status predicts outcome of acute myeloid leukaemia patients undergoing T-cell replete haploidentical transplantation. An analysis from the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT).微小残留病状态可预测接受 T 细胞充足的单倍体相合移植的急性髓系白血病患者的结局。来自欧洲血液和骨髓移植学会（EBMT）急性白血病工作组（ALWP）的分析。
Br J Haematol. 2018 Nov;183(3):411-420. doi: 10.1111/bjh.15540. Epub 2018 Aug 16.
5
[Immunophenotyping in acute leukemia: detection of minimal residual disease].[急性白血病的免疫表型分析：微小残留病的检测]
Orv Hetil. 2000 Nov 12;141(46):2487-92.
6
Immunophenotypic analysis of bone marrow B lymphocyte precursors (hématogones) by flow cytometry.通过流式细胞术对骨髓B淋巴细胞前体（造血细胞）进行免疫表型分析。
Clin Lab Sci. 2009 Fall;22(4):208-15.
7
Absence of leukaemic CD34 cells in acute myeloid leukaemia is of high prognostic value: a longstanding controversy deciphered.急性髓系白血病中白血病性CD34细胞的缺失具有高度预后价值：解开一个长期存在的争议。
Br J Haematol. 2015 Oct;171(2):227-238. doi: 10.1111/bjh.13572. Epub 2015 Jun 24.
8
Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia.
Lancet. 2001 Oct 13;358(9289):1239-41. doi: 10.1016/S0140-6736(01)06355-3.
9
Minimal residual disease evaluation by flow cytometry is a complementary tool to cytogenetics for treatment decisions in acute myeloid leukaemia.通过流式细胞术评估微小残留病是急性髓系白血病治疗决策中细胞遗传学的一种补充工具。
Leuk Res. 2016 Jan;40:1-9. doi: 10.1016/j.leukres.2015.10.002. Epub 2015 Oct 22.
10
The prognostic value of hematogones in patients with acute myeloid leukemia.幼稚血细胞在急性髓系白血病患者中的预后价值。
Am J Hematol. 2016 Jun;91(6):566-70. doi: 10.1002/ajh.24350. Epub 2016 Apr 13.

本文引用的文献

1
Dynamic changes in the level of WT1 as an MRD marker to predict the therapeutic outcome of patients with AML with and without allogeneic stem cell transplantation.WT1 水平的动态变化作为 MRD 标志物，预测伴有和不伴有异基因干细胞移植的 AML 患者的治疗结果。
Mol Med Rep. 2019 Sep;20(3):2426-2432. doi: 10.3892/mmr.2019.10440. Epub 2019 Jun 28.
2
The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients.评估微小残留病与体细胞突变对预测急性髓系白血病患者预后的作用。
Cancer Cell Int. 2019 Apr 4;19:83. doi: 10.1186/s12935-019-0807-0. eCollection 2019.
3
Combining flow cytometry and assessment improves the prognostic value of pre-transplant minimal residual disease in acute myeloid leukemia.
结合流式细胞术和评估可提高急性髓系白血病移植前微小残留病的预后价值。
Haematologica. 2017 Sep;102(9):e348-e351. doi: 10.3324/haematol.2017.167254. Epub 2017 May 11.
4
The prognostic value of hematogones in patients with acute myeloid leukemia.幼稚血细胞在急性髓系白血病患者中的预后价值。
Am J Hematol. 2016 Jun;91(6):566-70. doi: 10.1002/ajh.24350. Epub 2016 Apr 13.
5
Acute Myeloid Leukemia.急性髓系白血病
N Engl J Med. 2015 Sep 17;373(12):1136-52. doi: 10.1056/NEJMra1406184.
6
Kinetics of hematogones in bone marrow samples from patients with non-Hodgkin lymphomas treated with rituximab-containing regimens: a flow cytometric study.含利妥昔单抗方案治疗的非霍奇金淋巴瘤患者骨髓样本中造血前体细胞的动力学：一项流式细胞术研究
Int J Hematol. 2015 Jul;102(1):59-66. doi: 10.1007/s12185-015-1798-9. Epub 2015 May 8.
7
Hematogones: an overview.血原细胞：概述。
Leuk Res. 2013 Nov;37(11):1404-11. doi: 10.1016/j.leukres.2013.07.024. Epub 2013 Aug 8.
8
Hematogones: a new prognostic factor for acute myeloblastic leukemia.造血祖细胞：急性髓细胞白血病的一个新的预后因素。
Blood. 2011 Jan 27;117(4):1315-8. doi: 10.1182/blood-2010-07-295378. Epub 2010 Nov 15.
9
Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study.通过标准化WT1检测进行实时定量聚合酶链反应检测急性髓系白血病微小残留病以加强风险分层：一项欧洲白血病网研究
J Clin Oncol. 2009 Nov 1;27(31):5195-201. doi: 10.1200/JCO.2009.22.4865. Epub 2009 Sep 14.
10
Prognostic impact of RT-PCR-based quantification of WT1 gene expression during MRD monitoring of acute myeloid leukemia.基于逆转录聚合酶链反应（RT-PCR）的WT1基因表达定量在急性髓系白血病微小残留病监测中的预后影响
Leukemia. 2005 Aug;19(8):1416-23. doi: 10.1038/sj.leu.2403809.